Screening and Brief Intervention for Prescription Stimulant Misuse and Diversion: Refining and Piloting a Curriculum for College Health Providers

针对处方兴奋剂滥用和转移的筛查和简短干预:为大学医疗服务提供者完善和试点课程

基本信息

项目摘要

ABSTRACT Prescription stimulant diversion ([PSD] i.e., the sharing, selling, or trading of prescription stimulants) and prescription stimulant misuse ([PSM] i.e., use without a prescription, use in excess of a prescription, or use for nonmedical purposes) are inter-related and co-occurring problems on college campuses. In addition, PSD and PSM are not limited to students with a prescription for stimulants (Lam et al., 2020; Garcia et al., 2022). Thus, there is a need to universally screen and intervene upon both behaviors. Prior research has shown college health providers [CHPs] are concerned about PSM and PSD, yet feel they lack training in strategies to address these behaviors (Loskutova et al., 2020). As such, CHPs serve as ideal professionals for training and implementing PSM and PSD intervention efforts. To that end, our team has developed a research- and theory- guided PSM and PSD screening and brief intervention [SBI] curriculum to be implemented by CHPs. The purpose of the proposed, three-year, R34 study is to engage CHPs and college students in the refining and piloting of a SBI to address PSM and PSD. After completing start-up activities to promote content validity and face validity, we propose three studies to achieve our three aims. In Study 1, a geographically diverse sample of CHPs recruited from the American College Health Association member directory will assess the appropriateness and clarity of the curriculum content, as well as provide insights on potential implementation barriers and strategies to overcome barriers. The feedback provided will be used to refine the existing curriculum prior to pilot testing (AIM 1: Refine a novel PSM and PSD SBI curriculum by engaging CHPs in the development process). The pilot test will be completed at the campus health center of one diverse university where PSD and PSM are prevalent. Students will be randomized to control, e-SBI, or face-to-face SBI delivered by trained CHPs. Study 2 will focus on the CHPs; all CHPs who receive training will complete an evaluation of the curriculum, and CHPs who implement the SBI will complete indicators of feasibility, acceptability, and implementation (via the Motivational Interviewing Treatment Integrity tool, qualitative interview, and quantitative survey; AIM 2: Pilot test feasibility, acceptability, and implementation of the intervention). Study 3 will run concurrently with Study 2, and will focus on the student participants. Acceptability of the intervention will be measured immediately after participation (AIM 2) and impact on student PSM and PSD outcomes will be measured at one-month follow-up (AIM 3: Evaluate the short-term impact of the and PSD). Our goal is to apply the knowledge gained to refine a curriculum that can be widely disseminated. Attainment of this goal could be applied to reduce morbidity and mortality related to PSM and PSD. applying fundamental knowledge about behavior to promote health.
摘要 处方兴奋剂转移([PSD]即,分享、销售或交易处方兴奋剂), 处方兴奋剂滥用([PSM]即,无处方使用、超处方使用或用于 非医疗目的)是大学校园中相互关联和共同发生的问题。此外,私营部门司和 PSM并不限于有兴奋剂处方的学生(Lam等人,2020年; Garcia等人,2022年)。因此,在本发明中, 有必要对这两种行为进行普遍筛查和干预。此前的研究表明, 卫生服务提供者(CHP)对PSM和PSD表示关注,但认为他们缺乏解决 这些行为(Loskutova等人,2020年)。因此,卫生防护中心是培训和 执行方案支助和行政司及私营部门司的干预工作。为此,我们的团队开发了一种研究和理论- 由卫生防护中心实施有指导的PSM和PSD筛查和简短干预[SBI]课程。 这项为期三年的R34研究的目的是让卫生防护中心和大学生参与提炼 并试行一个履行机构来处理方案支助和行政管理以及私营部门司的问题。完成启动活动后,促进内容有效性 和表面效度,我们提出了三个研究,以实现我们的三个目标。在研究1中,一个地理上不同的 从美国大学健康协会成员目录中招募的CHP样本将评估 课程内容的适当性和清晰度,并提供有关潜在实施的见解 障碍和克服障碍的战略。提供的反馈将用于完善现有的 试点测试之前的课程(目标1:通过让CHP参与 发展过程)。试点测试将在一所多元化大学的校园健康中心完成 其中PSD和PSM普遍存在。学生将被随机分配到对照组、e-SBI组或面对面SBI组 由经过培训的卫生防护中心提供。第二项研究将集中于卫生防护中心;所有接受培训的卫生防护中心将完成一项 评估课程,执行SBI的卫生防护中心将完成可行性指标, 可接受性和实施(通过动机性访谈治疗完整性工具,定性 访谈和定量调查;目标2:试点测试的可行性,可接受性和实施 干预)。研究3将与研究2同时进行,重点是学生参与者。接受性 的干预措施将在参与后立即测量(AIM 2)和对学生PSM的影响, 将在一个月随访时测量PSD结局(AIM 3:评价 PSD)。我们的目标是应用所获得的知识来完善 可以广泛传播的课程。实现这一目标可用于降低发病率, 与PSM和PSD相关的死亡率。 运用行为学的基本知识来促进健康。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Niloofar Bavarian其他文献

Niloofar Bavarian的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Niloofar Bavarian', 18)}}的其他基金

Exploring deterrents to prescription stimulant diversion and misuse-related behaviors
探索处方兴奋剂转移和滥用相关行为的威慑因素
  • 批准号:
    9926499
  • 财政年份:
    2018
  • 资助金额:
    $ 26.91万
  • 项目类别:

相似海外基金

Antecedents of Adult Physical Health and Cognitive Risks for Alzheimer's Disease and Related Dementias (ADRD) in Adolescent Family Experiences: A Prospective, Longitudinal Adoption Study
青少年家庭经历中成人身体健康和阿尔茨海默氏病及相关痴呆症 (ADRD) 认知风险的前因:一项前瞻性、纵向收养研究
  • 批准号:
    10464655
  • 财政年份:
    2022
  • 资助金额:
    $ 26.91万
  • 项目类别:
Antecedents of Adult Physical Health and Cognitive Risks for Alzheimer's Disease and Related Dementias (ADRD) in Adolescent Family Experiences: A Prospective, Longitudinal Adoption Study
青少年家庭经历中成人身体健康和阿尔茨海默氏病及相关痴呆症 (ADRD) 认知风险的前因:一项前瞻性、纵向收养研究
  • 批准号:
    10630366
  • 财政年份:
    2022
  • 资助金额:
    $ 26.91万
  • 项目类别:
Adolescent Primary Care Adoption of Substance Use SBI
青少年初级保健药物使用 SBI
  • 批准号:
    6952450
  • 财政年份:
    2004
  • 资助金额:
    $ 26.91万
  • 项目类别:
Adolescent Primary Care Adoption of Substance Use SBI
青少年初级保健药物使用 SBI
  • 批准号:
    6861561
  • 财政年份:
    2004
  • 资助金额:
    $ 26.91万
  • 项目类别:
Adoption and Implementation of Adolescent EBT State-Wide
全州范围内青少年 EBT 的采用和实施
  • 批准号:
    6741059
  • 财政年份:
    2003
  • 资助金额:
    $ 26.91万
  • 项目类别:
Adoption and Implementation of Adolescent EBT State-Wide
全州范围内青少年 EBT 的采用和实施
  • 批准号:
    6929083
  • 财政年份:
    2003
  • 资助金额:
    $ 26.91万
  • 项目类别:
Adoption and Implementation of Adolescent EBT State-Wide
全州范围内青少年 EBT 的采用和实施
  • 批准号:
    6806541
  • 财政年份:
    2003
  • 资助金额:
    $ 26.91万
  • 项目类别:
LONGITUDINAL ADOPTION STUDY OF ADOLESCENT SUBSTANCE EXPERIMENTATION
青少年物质实验的纵向采用研究
  • 批准号:
    6335012
  • 财政年份:
    2000
  • 资助金额:
    $ 26.91万
  • 项目类别:
LONGITUDINAL ADOPTION STUDY OF ADOLESCENT SUBSTANCE EXPERIMENTATION
青少年物质实验的纵向采用研究
  • 批准号:
    6104174
  • 财政年份:
    1999
  • 资助金额:
    $ 26.91万
  • 项目类别:
LONGITUDINAL ADOPTION STUDY OF ADOLESCENT SUBSTANCE EXPERIMENTATION
青少年物质实验的纵向采用研究
  • 批准号:
    6270052
  • 财政年份:
    1998
  • 资助金额:
    $ 26.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了